Integrins are widely expressed cell-adhesion molecules with key roles in thrombosis, inflammation and cancer, and as a result are important drug targets. Inhibitors of αIIbβ3, α4 and αLβ2 integrins ...
WALTHAM, Mass., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback